Search results
Vepdegestrant shows promise in breast cancer trial By Investing.com
Investing.com· 11 hours agoArvinas, Inc. (NASDAQ: ARVN) and Pfizer Inc. (NYSE: NYSE:PFE) today announced continued positive...
Pfizer offers up to $250 mln to settle thousands of Zantac cancer lawsuits, FT reports
Reuters· 17 hours agoPfizer has agreed offer payment of up to $250 million to settle more than 10,000 lawsuits in the...
Pfizer offers up to $250 million to settle Zantac cancer lawsuits, FT reports
AOL· 17 hours agoThe drugmaker was set to pay between $200 million and $250 million in the settlement, the newspaper reported, citing two people briefed on the deal. The settlement was disclosed in a court filing ...
Posts Claim Falsely That AstraZeneca Is Withdrawing Its COVID Vaccine Because of Blood Clots
The Dispatch via Yahoo News· 6 hours agoThe U.S. contracted with AstraZeneca early in the pandemic for the delivery of 300 million doses of...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 2 days agoPfizer stock jumped to its 50-day moving average in early May after the company beat first-quarter...
Pfizer Offers up to $250 Million to Settle Thousands of Zantac Cancer Lawsuits, FT Reports
US News & World Report· 17 hours agoUS News is a recognized leader in college, grad school, hospital, mutual fund, and car rankings. Track elected officials, research health conditions, and find news you can use in politics, business, health, and education.
Pfizer Follows Eli Lilly's Footsteps To Sell Medicines Directly To Patients
Benzinga via Yahoo Finance· 3 days agoPfizer Inc (NYSE:PFE) is looking to build on the success of its COVID-19 vaccine rollout by...
A Struggling Pfizer Looks for Help From a Wall Streeter
Barrons.com· 6 days agoAs the big drugmaker tries to turn its fortunes around by focusing on oncology, it has turned to a...
Pfizer Inc. Just Beat EPS By 61%: Here's What Analysts Think Will Happen Next
Simply Wall St. via Yahoo Finance· 5 days agoPfizer Inc. (NYSE:PFE) just released its first-quarter report and things are looking bullish. It was...
Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in Pfizer Stock | The Motley...
The Motley Fool· 4 days agoPfizer (PFE -0.21%) stock has struggled over the past year, losing around 28% of its value. Its...